+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Heart Failure Drug"

From
From
Cardiac Troponin Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Cardiac Troponin Market Analysis & Forecast to 2024-2034

  • Report
  • March 2024
  • 200 Pages
  • Global
From
From
Medications For Heart Failure Global Market Report 2025 - Product Thumbnail Image

Medications For Heart Failure Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Chronic Heart Failure - Epidemiology Forecast - 2034 - Product Thumbnail Image

Chronic Heart Failure - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 165 Pages
  • Global
From
From
From
From
From
Heart Failure - Epidemiology forecast- 2032 - Product Thumbnail Image

Heart Failure - Epidemiology forecast- 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Congestive Heart Failure (CHF) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Congestive Heart Failure (CHF) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
Loading Indicator

The Heart Failure Drug market is a subset of the Cardiovascular Drugs market, which includes drugs used to treat a variety of heart-related conditions. Heart Failure Drugs are used to treat heart failure, a condition in which the heart is unable to pump enough blood to meet the body's needs. These drugs can help reduce symptoms, improve quality of life, and reduce the risk of death. Commonly used Heart Failure Drugs include ACE inhibitors, beta blockers, diuretics, and angiotensin receptor blockers. These drugs work by reducing the workload on the heart, improving blood flow, and reducing fluid buildup in the body. Some companies in the Heart Failure Drug market include Pfizer, Novartis, Merck, Sanofi, and Bristol-Myers Squibb. Show Less Read more